Enthesitis: Recognition, Clinical Associations, and Management
Introduction
Enthesitis refers to inflammation at the entheses - the sites where tendons, ligaments, fascia, or joint capsules insert into bone. It's a hallmark feature of spondyloarthritides but can be seen in various rheumatological and non-rheumatological conditions. This review examines the common sites of enthesitis, their clinical recognition, associated conditions, and current management approaches.
Pathophysiology
Entheses are specialized structures designed to dissipate mechanical stress. They consist of:
Fibrocartilaginous transition zones
Adjacent synovium and bursa
Surrounding adipose tissue
Associated bone marrow
The "enthesis organ" concept recognizes these structures function as an integrated unit. Inflammation may result from:
Mechanical stress triggering an inflammatory response
Immune dysregulation, particularly involving IL-23/IL-17 axis
Genetic predisposition (especially HLA-B27)
Microbial triggers (gut microbiome dysbiosis)
Common Sites of Enthesitis
Lower Extremity
Achilles tendon insertion - posterior calcaneus
Plantar fascia insertion - inferior calcaneus
Patellar tendon insertions - inferior patella and tibial tuberosity
Quadriceps tendon insertion - superior patella
Iliac crest - gluteal muscle attachments
Greater trochanter - gluteal tendons
Upper Extremity
Lateral epicondyle - common extensor tendon
Medial epicondyle - common flexor tendon
Supraspinatus insertion - greater tuberosity of humerus
Axial Skeleton
Anterior chest wall - costochondral and sternoclavicular junctions
Spinous processes - interspinous ligaments
Iliac crests - abdominal muscle attachments
Pubic symphysis
Clinical Recognition
Symptoms
Localized pain at insertion sites
Pain exacerbated by activity and tension on the affected tendon/ligament
Morning stiffness at the site
Decreased range of motion in adjacent joints
Physical Examination
Localized tenderness on palpation at insertion sites
Potential swelling or erythema
Pain with resistance testing of the involved muscle-tendon unit
Decreased flexibility
Standardized Assessment Tools
Leeds Enthesitis Index (LEI) - examines 6 sites (bilateral lateral epicondyles, medial femoral condyles, Achilles tendon insertions)
Spondyloarthritis Research Consortium of Canada (SPARCC) Enthesitis Index - 16 sites
Maastricht Ankylosing Spondylitis Enthesitis Score (MASES) - 13 sites
Clinical Associations
Spondyloarthritides
Ankylosing Spondylitis (AS) - predominantly axial involvement
Psoriatic Arthritis (PsA) - affects 30-50% of patients
Reactive Arthritis - following gastrointestinal or genitourinary infections
Enteropathic Arthritis - associated with IBD
Undifferentiated Spondyloarthritis
Other Rheumatological Conditions
Rheumatoid Arthritis - less common but can occur
Systemic Lupus Erythematosus - rare
SAPHO Syndrome (Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis)
Non-Rheumatological Conditions
Mechanical Overuse - sports or occupation-related
Metabolic Disorders
Diabetes mellitus
Hyperuricemia/gout
Hyperlipidemia
Fibromyalgia - can mimic or coexist with enthesitis
Osteoarthritis - insertional tendinopathy with mechanical causes
Diagnostic Approach
Imaging Modalities
Ultrasound - first-line imaging tool
Findings: hypoechogenicity, thickening, erosions, enthesophytes, Doppler signal
Advantages: accessible, dynamic, no radiation
Magnetic Resonance Imaging (MRI)
Findings: bone marrow edema, soft tissue inflammation
Advantages: superior for deep entheses, detects early changes
Radiography
Limited for early detection
Useful for chronic changes: erosions, enthesophytes
Laboratory Assessment
Acute phase reactants (ESR, CRP) - often normal in isolated enthesitis
HLA-B27 testing - relevant for spondyloarthritis diagnosis
Rheumatoid factor and anti-CCP antibodies - usually negative
Consider infectious workup if reactive arthritis suspected
Management Approaches
Non-Pharmacological
Physical Therapy
Stretching and strengthening exercises
Correction of biomechanical abnormalities
Proper footwear with orthotic support
Activity Modification
Reduction of mechanical stress
Ergonomic adjustments
Load management in athletes
Local Measures
Ice/heat application
Bracing or taping when appropriate
Pharmacological
First-Line
NSAIDs - both topical and oral
COX-2 inhibitors for those with GI concerns
Local Therapy
Corticosteroid injections - ultrasound-guided when necessary
Caution: potential tendon weakening with repeated injections
Disease-Modifying Antirheumatic Drugs (DMARDs)
Conventional DMARDs (methotrexate, sulfasalazine, leflunomide)
Limited efficacy for isolated enthesitis
Biologic Therapies
TNF inhibitors (adalimumab, etanercept, infliximab, golimumab, certolizumab)
IL-17 inhibitors (secukinumab, ixekizumab)
IL-23/IL-12 inhibitors (ustekinumab)
JAK inhibitors (tofacitinib, upadacitinib)
Management Based on Underlying Condition
SpA-related enthesitis - escalate to biologics if inadequate NSAID response
Mechanical enthesitis - focus on physical therapy and biomechanical correction
Metabolic causes - address underlying disorder
Monitoring and Prognosis
Regular clinical assessment using standardized enthesitis indices
Periodic imaging in selected cases
Evaluation of impact on function and quality of life
Consider enthesitis as a predictor of disease severity in SpA
Emerging Therapies and Future Directions
Novel biologics targeting specific inflammatory pathways
Personalized therapy based on genetic and biomarker profiles
Advanced imaging for early detection and monitoring
Biomechanical interventions for prevention
Conclusion
Enthesitis represents a key clinical feature in spondyloarthritides and other rheumatic conditions. Proper recognition requires thorough clinical examination and appropriate imaging. Management should address the underlying cause while providing symptomatic relief. A multidisciplinary approach involving rheumatologists, physiatrists, orthopedists, and physical therapists offers the best outcomes for patients with enthesitis.
No comments:
Post a Comment